Fresenius SE & Co KGaA (FRA:FRE) Given a €53.00 Price Target at Goldman Sachs Group

Goldman Sachs Group set a €53.00 ($61.63) target price on Fresenius SE & Co KGaA (FRA:FRE) in a report released on Thursday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Other equities analysts also recently issued research reports about the company. Warburg Research set a €63.00 ($73.26) price objective on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Thursday, February 13th. HSBC set a €53.00 ($61.63) price objective on Fresenius SE & Co KGaA and gave the stock a neutral rating in a report on Thursday, November 21st. Berenberg Bank set a €72.10 ($83.84) price objective on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Monday, February 17th. Sanford C. Bernstein set a €52.00 ($60.47) price objective on Fresenius SE & Co KGaA and gave the stock a neutral rating in a report on Tuesday, November 12th. Finally, Deutsche Bank set a €65.00 ($75.58) price objective on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Wednesday, February 12th. Eight research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has a consensus rating of Buy and a consensus target price of €56.37 ($65.54).

FRA:FRE opened at €49.66 ($57.74) on Thursday. The stock’s 50 day moving average price is €48.56 and its 200 day moving average price is €46.63. Fresenius SE & Co KGaA has a 52 week low of €60.16 ($69.95) and a 52 week high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Read More: What is a stock buyback?

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.